BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Takeuchi M, Takino JI, Sakasai-Sakai A, Takata T, Ueda T, Tsutsumi M, Hyogo H, Yamagishi SI. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. World J Hepatol 2014; 6(12): 880-893 [PMID: 25544875 DOI: 10.4254/wjh.v6.i12.880]
URL: https://www.wjgnet.com/1948-5182/full/v6/i12/880.htm
Number Citing Articles
1
Eva Gatineau, Sergio Polakof, Dominique Dardevet, Laurent Mosoni. Similarities and interactions between the ageing process and high chronic intake of added sugarsNutrition Research Reviews 2017; 30(2): 191 doi: 10.1017/S0954422417000051
2
Jun-ichi Takino, Takuma Sato, Takumi Kanetaka, Kasumi Okihara, Kentaro Nagamine, Masayoshi Takeuchi, Takamitsu Hori. RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cellsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82619-0
3
Ethan J. Anderson, Giulio Vistoli, Lalage A. Katunga, Katsuhiko Funai, Luca Regazzoni, T. Blake Monroe, Ettore Gilardoni, Luca Cannizzaro, Mara Colzani, Danilo De Maddis, Giuseppe Rossoni, Renato Canevotti, Stefania Gagliardi, Marina Carini, Giancarlo Aldini. A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stressJournal of Clinical Investigation 2018; 128(12): 5280 doi: 10.1172/JCI94307
4
Masayoshi Takeuchi. Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyleDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00614-3
5
Masayoshi Takeuchi. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesDiagnostics 2016; 6(2): 23 doi: 10.3390/diagnostics6020023
6
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Mikihiro Tsutsumi. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDNutrients 2017; 9(6): 634 doi: 10.3390/nu9060634
7
Mona M. Allam, Reham M. Ibrahim, Walaa Bayoumie El Gazzar, Mona A. Said. Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1/TLR4/NF-κB signaling pathway in a diabetic rat model of non-alcoholic fatty liver diseaseArchives of Physiology and Biochemistry 2021; : 1 doi: 10.1080/13813455.2021.1975758
8
Xin Sun, Yan Zhang, Meilin Xie. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver diseaseActa Pharmaceutica 2017; 67(1): 1 doi: 10.1515/acph-2017-0007
9
Takanobu Takata, Akiko Sakasai-Sakai, Tadashi Ueda, Masayoshi Takeuchi. Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular diseaseScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-39202-5
10
Jun-ichi Takino, Kentaro Nagamine, Takamitsu Hori, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(23): 2459-2469 doi: 10.4254/wjh.v7.i23.2459
11
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, Giovanni Targher. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?Journal of Hepatology 2018; 68(2): 335 doi: 10.1016/j.jhep.2017.09.021
12
Wei Wang, Zhixi Chen, Tiansheng Zheng, Ming Zhang. Xanthohumol alleviates T2DM-induced liver steatosis and fibrosis by mediating the NRF2/RAGE/NF-κB signaling pathwayFuture Medicinal Chemistry 2021; 13(23): 2069 doi: 10.4155/fmc-2021-0241
13
Jingjing Cai, Meng Xu, Xiaojing Zhang, Hongliang Li. Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular DiseasesAnnual Review of Pathology: Mechanisms of Disease 2019; 14(1): 153 doi: 10.1146/annurev-pathmechdis-012418-013003
14
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell DamageBiomolecules 2021; 11(3): 387 doi: 10.3390/biom11030387
15
UEG Week 2016 Poster PresentationsUnited European Gastroenterology Journal 2016; 4(5_suppl): A157 doi: 10.1177/2050640616663689
16
Rohini Mehta, Gladys Shaw, Peter Masschelin, Sean Felix, Munkzhul Otgonsuren, Ancha Baranova, Zachary Goodman, Zobair Younossi, Barry I. Hudson. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)PLOS ONE 2018; 13(6): e0199294 doi: 10.1371/journal.pone.0199294
17
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic SteatohepatitisInflammation 2019; 42(3): 1056 doi: 10.1007/s10753-019-00967-6
18
Atsushi Iwamura, Masahito Ito, Hideaki Mitsui, Jun Hasegawa, Keigo Kosaka, Ichiro Kino, Minoru Tsuda, Miki Nakajima, Tsuyoshi Yokoi, Toshiyuki Kume. Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assaysToxicology in Vitro 2015; 30(1): 241 doi: 10.1016/j.tiv.2015.10.013
19
Mohd W. A. Khan, Ahmed A. Otaibi, Arwa F. M. Alhumaid, Abdulmohsen K. D. Alsukaibi, Asma K. Alshamari, Eida M. Alshammari, Salma A. Al-Zahrani, Ahmed Y. M. Almudyani, Subuhi Sherwani. Garlic Extract: Inhibition of Biochemical and Biophysical Changes in Glycated HSAApplied Sciences 2021; 11(22): 11028 doi: 10.3390/app112211028
20
Takanobu Takata, Akiko Sakasai-Sakai, Jun-ichi Takino, Masayoshi Takeuchi. Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat LiverNutrients 2019; 11(7): 1612 doi: 10.3390/nu11071612
21
Mona M. Allam, Walaa B. El gazzar. Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat modelArchives of Physiology and Biochemistry 2018; 124(1): 10 doi: 10.1080/13813455.2017.1348362